3D bioprinting uses 15% GelMA and 0.5% LAP to create precise and reproducible tissue models. Photopolymerization at 405 nm and low/intermediate speed printing ensure high cell viability. The use of viscoelastic supports such as Pluronic allows for complex geometries without cell damage. Modular systems such as MagMix easily integrate existing platforms, improving

Optimizing additive production requires a holistic vision that includes not only print time, but also preparation phases, order aggregation, and post-processing. Often overlooked, these latter stages represent the true bottlenecks. To improve efficiency and reduce delivery times from 3 days to 3 hours, it is essential to integrate the entire production flow into a system

Next-generation photopolymer resins cost more because they are formulated to emulate the properties of engineering plastics like PP or TPU, with chemical precision and control of mechanical characteristics. They are not simple liquids: each resin is designed for specific applications, ensuring quality, durability, and performance similar to injection molding. The difference in pr

An artificial intelligence model developed by KIMS and Max Planck Institute predicts the mechanical properties of metal components produced with LPBF, analyzing pore morphology without destructive testing.

The real uptime of industrial 3D printers exceeds 90%, with less than 73 hours of annual downtime. Metrics such as MTBF and MTTR are essential for evaluating reliability. The difference between hobby and industry lies in construction details: robust frames, mechanical auto-leveling, and automation reduce dead times. The main causes of downtime are thermal instability, mechanical wear, and human errors.

MedCAD has obtained FDA authorization for AccuStride, a system that brings personalized surgical planning for lower limbs to 3D-printed titanium guides, with delivery in 5 days. By integrating imaging, digital design, and rapid production, it reduces operating times and complications.

The additive manufacturing sector is consolidating on vertical niches such as aerospace, medical, and foundry, abandoning the logic of horizontal coverage. The companies that survive focus on specialization, integration into client workflows, and reliable solutions, not just innovation. Success now depends on the ability to generate concrete economies and ensure uptime and repeatability.

Desktop 3D printing today offers industrial-grade precision at contained costs, but with limits on scale and speed. Solutions like the microArch S150 and its Ultra upgrade balance precision and throughput for R&D and pilot production. Entry-level post-processors like the M4 Basic improve finish, albeit with dimensional limits. The right choice depends on the specific use case.

The 3D market is splitting: on one hand, entry-level systems under 2.500$ are growing by more than 30%; on the other, high-end industrial platforms are struggling. Three sectors are driving demand: aerospace, defense, and healthcare. China is recording strong increases in metal PBF. Business models are differentiating: suppliers are focusing on specific segments to remain competitive. Future growth

Additive Manufacturing (AM) succeeds in production only when applied to specific cases with high functional requirements, not to replace traditional methods, but to solve needs that these cannot satisfy. Success depends on consolidated designs, controlled materials, fixed parameters, and disciplined post-processing. Sectors such as aerospace, medical, and tooling exploit the

Integrated metrology in 3D scanners enables real-time quality control, reducing time and costs. Thanks to advanced sensors, geometric algorithms, and connectivity, these systems process dimensional data directly during scanning, integrating with metrology platforms and production processes. Despite some technological limitations, they represent a breakthrough for high-

3D microneedles based on polysaccharides represent a new frontier for cancer immunotherapy. These biodegradable structures penetrate the skin to release drugs directly into the tumor microenvironment, reducing side effects and increasing therapeutic efficacy. Thanks to 3D printing, it is possible to customize their shape and composition for targeted and controlled release. I